The cell of origin affects mouse glioblastoma development and phenotype A neural stem-cell-like origin produces higher malignancy and drug sensitivity The mouse cell origin signature separates distinct phenotypes of human glioblastoma The mouse cell origin signature predicts glioblastoma cell response to temozolomide